FIELD: medicine.
SUBSTANCE: described is the use of desethylamiodarone for treating or preventing atrial fibrillation by oral administration. Desethylamiodarone is administered orally, sublingually or buccally. Desethylamiodarone is administered once a day.
EFFECT: use of desethylamiodarone reduces frequency of cases of atrial fibrillation, duration of attacks of atrial fibrillation, provides protection against life-threatening arrhythmias.
3 cl, 11 dwg, 9 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| N-1-[(4-FLUOROPHENYL)-2-(1-ETHYL-4-PIPERIDYL)-ETHYL]-4-NITROBENZAMIDE HYDROCHLORIDE EXHIBITING ANTIARHYTHMIC AND ANTIFIBRILLATORY ACTIVITY | 2009 |
|
RU2415128C2 |
| METHOD FOR PREVENTION OF ATRIAL FIBRILLATION IN OPEN LUNG SURGERIES OF ONCOLOGY DISEASES | 2014 |
|
RU2574187C1 |
| METHOD FOR TREATING ATRIAL FIBRILLATION IN CASE OF MYOCARDIAL INFARCTION | 2005 |
|
RU2268713C1 |
| ANTI-ARRHYTHMIC MEDICAMENT "TIODARON" | 2004 |
|
RU2292885C2 |
| METHOD FOR SINUS RHYTHM RESTORATION IN ATRIAL FLUTTER TYPE 1 | 2010 |
|
RU2448698C2 |
| METHOD FOR EVALUATING THE EFFECT OF PROPHYLACTIC ANTI-ARRHYTHMIC THERAPY IN PATIENTS WITH FREQUENT PAROXYSMS OF ATRIAL FIBRILLATION AND FLUTTER ACCORDING TO DATA OF SPONTANEOUS RELAPSES OF ARRHYTHMIA | 2006 |
|
RU2315551C2 |
| AGENT POSSESSING ANTIARRHYTHMIC, ANTIFIBRILLATORY, ANTI-ISCHEMIC ACTION, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2477130C1 |
| METHOD FOR PREVENTION OF CARDIAC RHYTHM DISTURBANCE IN CORONARY BYPASS | 2009 |
|
RU2392939C1 |
| ANTIARRYTHMIC AGENT | 1983 |
|
RU2068261C1 |
| METHOD FOR PREDICTION OF ANTIARRHYTHMIC THERAPY EFFECIENCY FOR CHILDREN | 2015 |
|
RU2611954C1 |
